These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 349571)

  • 1. Inhibition of insulin and glucagon secretion by somatostatin: are there indirect effects?
    Smith PH; Chen M; Woods SC; Ensinck JW; Porte D
    Proc Soc Exp Biol Med; 1978 Apr; 157(4):643-7. PubMed ID: 349571
    [No Abstract]   [Full Text] [Related]  

  • 2. Remarkable potency of somatostatin as a glucagon suppressant.
    Samols E; Harrison J
    Metabolism; 1976 Nov; 25(11 Suppl 1):1495-7. PubMed ID: 790096
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of phentolamine on the somatostatin-induced inhibition of glucagon and insulin secretion.
    Kaneto A; Kajinuma H; Kaneko T; Kosaka K
    Metabolism; 1978 Aug; 27(8):901-10. PubMed ID: 209286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin-28 does not regulate islet function in the dog.
    Klaff LJ; Dunning BE; Taborsky GJ
    Endocrinology; 1988 Dec; 123(6):2668-74. PubMed ID: 2904358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of somatostatin on pancreatic endocrine--experiment by somatostatin infusion into the pancreaticoduodenal artery in dogs--(author's transl)].
    Nakabayashi H; Yoshimitsu K; Kishitani M; Ueda M; Kawato M
    Nihon Naibunpi Gakkai Zasshi; 1976 Mar; 52(3):218-26. PubMed ID: 786754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central factors in the control of insulin and glucagon secretion.
    Porte D; Woods SC; Chen M; Smith PH; Ensinck JW
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):127-33. PubMed ID: 775499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of a paracrine role for pancreatic somatostatin in vivo.
    Taborsky GJ
    Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of glucagon release by addition of anti-stomatostatin serum to islets of Langerhans in vitro.
    Barden N; Lavoie M; Dupont A; Côté J; Côté JP
    Endocrinology; 1977 Aug; 101(2):635-8. PubMed ID: 328268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs.
    Gordin A; Meyers C; Arimura A; Coy DH; Schally AV
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):833-41. PubMed ID: 335762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.
    Taborsky GJ; Smith PH; Porte D
    Am J Physiol; 1979 Feb; 236(2):E123-8. PubMed ID: 369388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of glucagon and insulin secretion from the perfused rat pancreas by a B-cell-selective somatostatin analog.
    Weir GC; Schwarz JA; Mathe CJ
    Metabolism; 1980 Jan; 29(1):68-70. PubMed ID: 6986012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues.
    Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET; Sandler S
    Regul Pept; 2007 Jan; 138(1):1-9. PubMed ID: 16935361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas.
    Qader SS; Håkanson R; Rehfeld JF; Lundquist I; Salehi A
    Regul Pept; 2008 Feb; 146(1-3):230-7. PubMed ID: 17942170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin inhibition of insulin and glucagon secretion in rat islet culture: reversal by ionophore A23187.
    Fujimoto WY; Ensinck JW
    Endocrinology; 1976 Jan; 98(1):259-62. PubMed ID: 765117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone release from pancreatic islets perfused from venous side.
    Kawai K; Chiba Y; Okuda Y; Yamashita K
    Diabetes; 1987 Mar; 36(3):256-60. PubMed ID: 2879756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of glucagon secretion by tetragastrin.
    Kaneto A; Mizuno Y; Tasaka Y; Kosaka K
    Endocrinology; 1970 May; 86(5):1175-80. PubMed ID: 4907835
    [No Abstract]   [Full Text] [Related]  

  • 17. Somatostatin-induced inhibition of insulin secretion from isolated islets of rat pancreas in presence of glucagon.
    Sieradzki J; Schatz H; Nierle C; Pfeiffer EF
    Horm Metab Res; 1975 Jul; 7(4):284-7. PubMed ID: 168138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new benzothiadiazine derivative, LN 5330: effects on pancreatic hormones.
    Hillaire-Buys D; Ribes G; Blayac JP; Loubatières-Mariani MM
    Diabetologia; 1984 Dec; 27(6):583-6. PubMed ID: 6152237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of neurotensin on insulin, glucagon, and somatostatin release from isolated pancreatic islets.
    Dolais-Kitabgi J; Kitabgi P; Brazeau P; Freychet P
    Endocrinology; 1979 Jul; 105(1):256-60. PubMed ID: 376297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin inhibits insulin and glucagon release by monolayer cell cultures of rat endocrine pancreas.
    Fujimoto WY; Ensinck JW; Williams RH
    Life Sci; 1974 Dec; 15(11):1999-2004. PubMed ID: 4621242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.